Atlas Trials

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism

Clinical trial NCT01067365 · COMPLETED

Trial details

NCT number
NCT01067365
Sponsor
Repros Therapeutics Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Secondary Hypogonadism
Start date
2006-03-01
Primary completion
2007-05-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.